Abstract
Inadequate vitamin D may be involved in the pathogenesis and or progression of several disorders, including connective tissue diseases. To determine the status of vitamin D in different stages of inflammatory arthritis, the levels of vitamin D in established rheumatoid arthritis (RA) and undifferentiated inflammatory arthritis (UIA) were compared with controls. Patients with RA and UIA entered the study. Serum 25-hydroxyvitamin D (25-OHD) was measured by ELISA method, and concentrations less than 20 ng/ml were considered as deficient levels. In statistical analysis, the Mann–Whitney U test was used for comparing differences between groups and logistic regression analysis with calculation of adjusted odds ratio (OR) was used to determine the association between serum 25-OHD deficiency and disease condition. A total of 108 RA, 39 UIA, and 239 controls were studied. There were no significant differences in mean serum 25-OHD level and frequency of serum 25-OHD deficiency between RA and controls (37 ± 37.7 vs. 33.2 ± 28.6 ng/ml, P = 0.96). But the mean serum 25-OHD level in UIA was significantly lower than in the controls (25.1 ± 23.9 vs. 33.2 ± 28.6 ng ml, P = 0.04). A significant positive association was observed between serum 25-OHD deficiency and UIA (56.4% vs. 35.5%, OR = 2.34, 95% CI, 1.18–4.65, P = 0.021) which remained significant after adjustment for sex and age (adjusted OR = 2.24, 95% CI, 1.01–4.55, P = 0.026). Whereas the association between serum 25-OHD deficiency and RA did not reach statistical significance (40.7% vs. 35.5%, OR = 1.24, 95% CI, 0.78–1.99). These findings indicate higher serum vitamin D deficiency in patients with ongoing arthritis rather than established arthritis. Respecting to deleterious effects of vitamin D deficiency on immune system and progressive nature of UIA, a significant proportion of high risk UIA can be recognized by serum 25-OHD determination.
Similar content being viewed by others
References
Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353–373
Gannagé-Yared MH, Tohmé A, Halaby G (2001) Hypovitaminosis D: a major worldwide public health problem. Presse Med 7(30):653–658
Adams JS, Hewison M (2010) Update in vitamin D. J Clin Endocrinol Metab 95:471–478
Cutulo M, Otsa K, Paolino S, Yrrus M, Veldi T, Seriolo B (2008) Vitamin D involvement in rheumatoid arthritis and systemic lupus erythgmatosus. Ann Rheum Dis 67:530–535
Pérez-López FR (2007) Vitamin D and its implications for musculoskeletal health in women: an update. Maturitas 58(2):117–137 (Epub 2007 Jun 29)
Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new etiological and therapeutic considerations. Ann Rheum Dis 66:1137–1142
Ranganathan P (2009) Genetics of bone loss in rheumatoid arthritis—role of vitamin D receptor polymorphisms. Rheumatology (Oxford) 48(4):342–346
Tetlove LC, Wolley DE (1999) The effect of 1 alpha 25-dihydroxyvitamin D3 on matrixmetalloproteinase and prostgalndin E2 production by cells of rheumatoid lesion. Arthritis Res 1:63–70
Albert PJ, Proal AD, Marshall TG (2009) Vitamin D: the alternative hypothesis. Autoimmun Rev 8(8):639–644
Szodoray P, Nakken B, Gaal J et al (2008) The complex role of vitamin D in autoimmune diseases. Scand J Immunol 68(3):261–269
Deluca HF, Cantorna MT (2001) Vitamin D: it’s role and uses in immunology. FASEB J 15:2579–2585
Kamen DL, Aranow C (2008) The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep 10:273–280
Alele JD, Kamen DL (2010) The importance of inflammation and vitamin D status in SLE-associated osteoporosis. Autoimmun Rev 9(3):137–139
Cutolo M, Otsa K (2008) Review: vitamin D, immunity and lupus. Lupus 17(1):6–10
Zold E, Szodoray P, Kappelmayer J et al (2008) Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther 10:R123
Damanhouri LH (2009) Vitamin D deficiency in Saudi patients with systemic lupus erythematosus. Saudi Med J 30:1291–1295
Turhanoğlu AD, Güler H, Yönden Z, Aslan F, Mansuroglu A, Ozer C (2010) The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rheumatol Int. doi:10.1007/s00296-010-1393-6
Craig SM, Yu F, Curtis JR et al (2010) Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. Rheumatol 37(2):275–281
Braun-Moscovici Y, Toledano K, Markovits D, Rozin A, Nahir AM, Balbir-Gurman A (2009) Vitamin D level: is it related to disease activity in inflammatory joint disease? Rheumatol Int. doi:10.1007/s00296-009-1251-6
Patel S, Farrager T, Berry J, Bunn D, Silman A, Symmons D (2007) Association between serum vitamin D metabolites levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 56:2143–2149
Arnett FC, Edworthy SN, Bloch DA et al (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Gottenberg JE, Miceli-Richard C, Ducot B, Goupille P, Combe B, Mariette X (2009) Markers of B—lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort. Arthritis Res Ther 11:R114
Heidari B, Firouzjahi A, Heidari P, Hajian K (2009) The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis. Ann Saudi Med 29(6):467–470
Szodoray P, Szabo Z, Kapitany A et al (2010) Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmune Rev 9:140–143
Caro-Oleas JL, Fernandez-Suarez A, Reneses CS, Porrino C, Nunez-Roldan A, Wichman SI (2008) Evaluation of third generation anti-CCP antibodies in the diagnosis of rheumatoid arthritis from undifferentiated polyarthritis after 4 years of follow—up. Clin Exp Rheumatol 26:461–463
Vaz CC, Couto M, Medeiros D et al (2009) Undifferentiated connective tissue disease: a seven—center cross-sectional a study of 184 patients. Clin Rheumatol 28:915–921
Kudo-Tanaka E, Ohshima S, Ishi M (2007) Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis. Clin Rheumatol 26:1627–1633
Emery P, Durez P, Dougados M et al (2010) Impact of T cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial). Ann Rheum Dis 69:510–516
Jeffery LE, Burke F, Mura M et al (2009) 1, 25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and Fox3. J Immunol 183:5458–5467
Cutolo M (2009) Vitamin D and autoimmune rheumatic disease. Rheumatology 48:210–212
Andjelkovic Z, Voojinivic J, Pejnovic N et al (1999) Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 17:453–456
Ruiz-Irastorza G, Gordo S, Olivares N, Egurbide MV, Aguirre C. (2010) Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity an damage. Arthritis Care Res (Hoboken) [Epub ahead of print]. doi:10.1002/acr.20186
Gaal J, Lakos G, Szodoray P et al (2009) Immunological and clinical effects of alphacalcidiol in patients with psoriatic arthropathy: results of an open, follow-up pilot study. Acta Derm Venerol 89:140–144
Gouch A, Sambrook P, Delvin J et al (1998) Effect of vitamin D receptor gene alleles on bone loss in early rheumatoid arthritis. J Rheumatol 25:864–868
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heidari, B., Hajian-Tilaki, K. & Heidari, P. The status of serum vitamin D in patients with rheumatoid arthritis and undifferentiated inflammatory arthritis compared with controls. Rheumatol Int 32, 991–995 (2012). https://doi.org/10.1007/s00296-010-1736-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1736-3